Focusing on angiosarcoma, because therapeutic advancements are very slow and alternative drugs and cellular models of this disease are urgently needed, we isolated a new angiosarcoma cell line from the biopsy of an angiosarcoma (AS) patient that we utilized to evaluate the expression of β-ARs and to test the antitumour potential of propranolol alone and in combination with docetaxel. The gene discussed is CTBP1; the disease is angiosarcoma.